Notes to editors
Nancy Devlin is Professor of Health Economics at City University. She was Fellow in Health Systems at The King's Fund at the time of writing.
Adrian Towse is Director of the Office of Health Economics. He undertakes research on policy and economic issues within the pharmaceutical, health care and biotechnology industries. He is a non-executive Director of the Oxford Radcliffe NHS Trust and is chair of its Clinical Governance Board.
Clive Pritchard is a researcher specialising in health technology assessment at the Office of Health Economics. His work includes examining the health care decision making processes of NICE, and similar organisations around the world.
The Office of Health Economics provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology industries. Its main areas of focus are: the pharmaceutical and biotechnology industry, health care systems - their financing and organisation, and the economics of health technology assessment.